- Lobbying
- Lobbying by Indivior, PLC (fka Reckitt Benckiser Pharmaceuticals, Inc.)
Lobbying Relationship
Bills mentioned
H.R.2872: Opioid Addiction Treatment Modernization Act
Sponsor: Larry Bucshon (R-Ind.)
H.R.1821: Opioid Overdose Reduction Act of 2015
Sponsor: Richard E. Neal (D-Mass.)
S.707: Opioid Overdose Reduction Act of 2015
Sponsor: Edward J. Markey (D-Mass.)
H.R.2536: TREAT Act
Sponsor: Brian Higgins (D-N.Y.)
S.1455: TREAT Act
Sponsor: Edward J. Markey (D-Mass.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Christy Ellerbee | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
Health Issues
Pharmacy
U.S. House of Representatives
Health Issues
Pharmacy
U.S. House of Representatives
Health Issues
Pharmacy
U.S. Senate
Health Issues
Pharmacy
U.S. House of Representatives
Health Issues
Pharmacy
U.S. House of Representatives
Health Issues
Pharmacy
Health Issues
Pharmacy
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate